pubmed-article:12957728 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12957728 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:12957728 | lifeskim:mentions | umls-concept:C1956346 | lld:lifeskim |
pubmed-article:12957728 | lifeskim:mentions | umls-concept:C0023823 | lld:lifeskim |
pubmed-article:12957728 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:12957728 | lifeskim:mentions | umls-concept:C1418754 | lld:lifeskim |
pubmed-article:12957728 | lifeskim:mentions | umls-concept:C0311404 | lld:lifeskim |
pubmed-article:12957728 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
pubmed-article:12957728 | lifeskim:mentions | umls-concept:C0700164 | lld:lifeskim |
pubmed-article:12957728 | lifeskim:mentions | umls-concept:C0456369 | lld:lifeskim |
pubmed-article:12957728 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:12957728 | pubmed:dateCreated | 2003-9-5 | lld:pubmed |
pubmed-article:12957728 | pubmed:abstractText | There is growing evidence that ox-LDL plays an important role during the atherosclerosis process and PON1 can significantly inhibit generation of lipid peroxidation during LDL oxidation and thus play a role in the in vivo protection by HDL against atherosclerosis. | lld:pubmed |
pubmed-article:12957728 | pubmed:language | eng | lld:pubmed |
pubmed-article:12957728 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12957728 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12957728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12957728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12957728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12957728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12957728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12957728 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12957728 | pubmed:month | Sep | lld:pubmed |
pubmed-article:12957728 | pubmed:issn | 0167-5273 | lld:pubmed |
pubmed-article:12957728 | pubmed:author | pubmed-author:PayzinSerdarS | lld:pubmed |
pubmed-article:12957728 | pubmed:author | pubmed-author:KayikciogluMe... | lld:pubmed |
pubmed-article:12957728 | pubmed:author | pubmed-author:AzarsizElifE | lld:pubmed |
pubmed-article:12957728 | pubmed:author | pubmed-author:Yildirim... | lld:pubmed |
pubmed-article:12957728 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12957728 | pubmed:volume | 91 | lld:pubmed |
pubmed-article:12957728 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12957728 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12957728 | pubmed:pagination | 43-51 | lld:pubmed |
pubmed-article:12957728 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:meshHeading | pubmed-meshheading:12957728... | lld:pubmed |
pubmed-article:12957728 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12957728 | pubmed:articleTitle | PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease. | lld:pubmed |
pubmed-article:12957728 | pubmed:affiliation | Department of Biochemistry, Ege University Faculty of Medicine, Bornova, Izmir, Turkey. | lld:pubmed |
pubmed-article:12957728 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12957728 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:12957728 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
pubmed-article:12957728 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:5444 | entrezgene:pubmed | pubmed-article:12957728 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12957728 | lld:entrezgene |
lhgdn:association:53260 | lhgdn:found_in | pubmed-article:12957728 | lld:lhgdn |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12957728 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12957728 | lld:pubmed |